These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 22149578

  • 1. Crofelemer for the treatment of secretory diarrhea.
    Cottreau J, Tucker A, Crutchley R, Garey KW.
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):17-23. PubMed ID: 22149578
    [Abstract] [Full Text] [Related]

  • 2. Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrhea.
    Yeo QM, Crutchley R, Cottreau J, Tucker A, Garey KW.
    Drugs Today (Barc); 2013 Apr; 49(4):239-52. PubMed ID: 23616951
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective.
    Biswal S.
    Recent Pat Antiinfect Drug Discov; 2014 Apr; 9(2):136-43. PubMed ID: 25851117
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Crofelemer: a review of its use in the management of non-infectious diarrhoea in adult patients with HIV/AIDS on antiretroviral therapy.
    Frampton JE.
    Drugs; 2013 Jul; 73(10):1121-9. PubMed ID: 23807722
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome.
    Nee J, Salley K, Ludwig AG, Sommers T, Ballou S, Takazawa E, Duehren S, Singh P, Iturrino J, Katon J, Lee HN, Rangan V, Lembo AJ.
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00110. PubMed ID: 31800542
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients.
    Mangel AW, Chaturvedi P.
    Digestion; 2008 Dec; 78(4):180-6. PubMed ID: 19092244
    [Abstract] [Full Text] [Related]

  • 13. CFTR inhibitors for treating diarrheal disease.
    Thiagarajah JR, Verkman AS.
    Clin Pharmacol Ther; 2012 Sep; 92(3):287-90. PubMed ID: 22850599
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discovery and development of antisecretory drugs for treating diarrheal diseases.
    Thiagarajah JR, Ko EA, Tradtrantip L, Donowitz M, Verkman AS.
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):204-9. PubMed ID: 24316107
    [Abstract] [Full Text] [Related]

  • 19. Developing novel antisecretory drugs to treat infectious diarrhea.
    de Hostos EL, Choy RK, Nguyen T.
    Future Med Chem; 2011 Aug; 3(10):1317-25. PubMed ID: 21859305
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.